评估电针治疗抗精神病药相关便秘的疗效与安全性:一项随机对照试验的研究方案
本研究为单中心、平行组、随机对照试验,受试者、结局评估者和统计师设盲,计划纳入112例抗精神病药相关便秘患者,按1:1随机分为电针组或假针刺组,疗程包括2周基线期、8周治疗期和12周随访期,主要结局为第1至8周平均每周完全自发性排便次数较基线的变化。
要点
- 主要结局为第1至8周平均每周完全自发性排便次数较基线的变化。
- 次要结局包括随访期完全自发性排便次数、自发性排便次数、总体应答率及多项量表评分。
核心结论
- 该研究旨在评估电针治疗抗精神病药相关便秘的疗效与安全性,研究结果将以同行评议论文形式发表,作为可靠证据。
研究设计与样本
- 单中心、平行组、随机对照试验,受试者、结局评估者和统计师设盲。
- 计划纳入112例参与者,按1:1比例随机分配至电针组或假针刺组。
- 每例参与者研究持续22周,包括2周基线评估期、8周治疗期和12周随访期。
主要发现
- 主要结局为第1至8周平均每周完全自发性排便次数(CSBMs)较基线的变化。
- 次要结局包括随访期平均每周CSBMs较基线的变化、平均每周自发性排便次数(SBMs)、总体CSBM应答率、Bristol粪便性状量表(BSFS)评分、排便用力程度、患者便秘症状评估(PAC-SYM)、患者便秘生活质量问卷(PAC-QOL)及简明精神病评定量表(BPRS)。
- 不良事件和药物使用将被记录。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Constipation is known as a common adverse effect of antipsychotics. Advice for its management remains inadequate. This study is designed to investigate the efficacy and safety of electro-acupuncture (EA) for antipsychotic-related constipation. METHODS: This is a single-centric, parallel-group, randomized controlled trial with blinded participants, outcome assessor, and statistician. One hundred twelve participants will be randomly assigned into the EA group or sham acupuncture (SA) group in a 1:1 ratio. The study will last for 22 weeks for each participant, including a 2-week baseline assessment period, an 8-week treatment period, and a follow-up for 12 weeks. The primary outcome is the change of mean weekly complete spontaneous bowel movements (CSBMs) during weeks 1 to 8 from baseline. Secondary outcomes include the change from baseline of mean weekly CSBMs during the follow-up period, mean weekly spontaneous bowel movements (SBMs), overall CSBM response rate, scores on Bristol Stool Form Scale (BSFS), straining level, Patient Assessment of Constipation Symptoms (PAC-SYM), Patient Assessment of Constipation Quality of life questionnaire (PAC-QOL), and Brief Psychiatric Rating Scale (BPRS). Adverse events and medicine use will be recorded as well. DISCUSSION: The study is designed based on a rigorous methodology to evaluate the efficacy and safety of EA for antipsychotic-related constipation. The finding will be published in peer-reviewed journals as reliable evidence. TRIAL REGISTRATION: ClinicalTrials.gov ChiCTR2000032582. Registered May 3, 2020, with the Chinese Clinical Trial Registry.
引用
- Yu FT, Long DH, Shi GX, et al. Evaluating the efficacy and safety of electro-acupuncture in patients with antipsychotic-related constipation: protocol for a randomized controlled trial. Trials. 2021. PMID: 34736504. doi:10.1186/s13063-021-05732-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。